INTELLIGENT BIO SOLUTIONS IN
INBS · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $1.51
- Today’s Low
- $1.45
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.54
- Previous Close
- $1.51
- Volume
- 20.13K
- Market Cap
- $5M
- P/E Ratio
- --
- EPS
- $-9.66
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 135 WEST, 41ST STREET, NEW YORK, NY, UNITED STATES, 10036
- Country
- US
- Listing Date
- 2020-12-23
- Fiscal Year End
- June
- Shares Outstanding
- 2.39M
- CIK
- 0001725430
- Website
- ibs.inc
Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven technologies, specifically designed for drug abuse testing and monitoring. Utilizing advanced scientific methodologies, INBS offers rapid and precise testing options that enhance clinical decision-making processes and improve patient outcomes. In a healthcare landscape increasingly reliant on innovative diagnostic tools, INBS is well-positioned to make substantial contributions to this evolving field, reinforcing its dedication to advancing healthcare quality and operational effectiveness.
Financial Metrics
Revenue
2026-06-30
$1.14M
2026-03-31
$1.06M
2025-12-31
$896.77K
2025-09-30
$1.11M
Operating Expenses
2026-06-30
$4.45M
2026-03-31
$3.35M
2025-12-31
$3.06M
2025-09-30
$3.14M
Net Income
2026-06-30
-$3.9M
2026-03-31
-$2.86M
2025-12-31
-$2.67M
2025-09-30
-$2.98M
Net Profit Margin
2026-06-30
-341.04%
2026-03-31
-269.86%
2025-12-31
-298.58%
2025-09-30
-268.3%
Earnings Per Share
2026-06-30
$-0.90
2026-03-31
$-1.80
2025-12-31
$-2.82
2025-09-30
$-0.35
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.92M
2026-03-31
-$2.57M
2025-12-31
-$2.34M
2025-09-30
-$2.68M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.14M | $1.06M | $896.77K | $1.11M |
| Operating Expenses | $4.45M | $3.35M | $3.06M | $3.14M |
| Net Income | -$3.9M | -$2.86M | -$2.67M | -$2.98M |
| Net Profit Margin | -341.04% | -269.86% | -298.58% | -268.3% |
| Earnings Per Share | $-0.90 | $-1.80 | $-2.82 | $-0.35 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.92M | -$2.57M | -$2.34M | -$2.68M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.